Clinical Trials Logo

Filter by:
NCT ID: NCT04563481 Not yet recruiting - Rehabilitation Clinical Trials

Effectiveness of Telerehabilitation on Scleroderma

Start date: May 1, 2022
Phase: N/A
Study type: Interventional

The effects of exercises performed by telerehabilitation on individuals with hand-affected scleroderma on range of motion, grip strength, function, sensation, daily life activities and general health will be compared with the effects of traditional physiotherapy practices.

NCT ID: NCT04563455 Completed - Clinical trials for Rheumatoid Arthritis

Relationship Between Grip Endurance, Disability of Upper Extremity and Quality of Life in Patients With RA

Start date: December 1, 2019
Phase:
Study type: Observational

The aim of this study is to investigate the relationship between grip endurance, disability of upper extremity and quality of life in patients with rheumatoid arthritis.

NCT ID: NCT04563312 Completed - Clinical trials for Functional Performance

Lower Limb Performance, Balance and Coordination Differences Between the Muay Thai Athletes and Recreational Bodybuilders

Start date: September 17, 2020
Phase: N/A
Study type: Interventional

Purpose: The aim of this study was to compare balance, coordination and lower extremity functional performances of Muay Thai (MT) athletes and bodybuilders (BB). Method: Seventeen athletes (14 men and 3 women; mean age: 20.65 + 2.34) engaged in MT and 18 (13 men and 5 women, mean age: 25.89 + 4.83) engaged in BB were included in the study. The Flamingo Balance Test and Y Balance Test were used to evaluate static and dynamic balance, respectively. Coordination was assessed using the Hexagon Test. Lower extremity functional performance was evaluated using the Single Leg Hop Test.

NCT ID: NCT04563182 Completed - Balance Clinical Trials

Relationship Between Gluteus Medius Muscle Strength, Balance and Jumping Performance in Professional Female Handball Players

Start date: September 17, 2020
Phase:
Study type: Observational

Background Balance and jumping mechanisms are important to prevent injuries in sports such as handball, which require immediately change of direction, jumping and landing strategy. Strong proximal stability is required for accurate jump performance and stability. Objective To investigate the relationship between gluteus medius strength and static, dynamic balance, horizontal and vertical jump performance. Design Prospective field trial study. Setting: Elite women handball players in Turkish Handball Super League. Patients (or Participants): Forty-two elite women handball players from Turkish Handball Super League were included in this study. Interventions (or assessment of risk factors) The Lafayette Hand-Held Dynamometer was used to determine the strength of the gluteus medius. Single leg hop (SLH) test was used for horizontal jump and Lafayette Vertimetric device was used for vertical jump (VJ) evaluation. Y Balance Test (YBT) was used for the dynamic balance with direction of anterior, posteriomedial, posteriolateral and Standing Stork Test (SST) with eyes closed for the measurement of static balance. Main outcome measurements Gluteus medius strength with hand dynamometer compared with YBT, SST, VJ and SLH tests.

NCT ID: NCT04562909 Recruiting - Premature Birth Clinical Trials

Evaluation of Postural Control in Premature Children

Start date: September 1, 2020
Phase:
Study type: Observational

To date, it is largely unknown whether preterm children experience balance problems and whether they have normal postural control. Assuming that postural adaptation is affected after preterm delivery because it depends on attention and fine motor control, the postural control and motor development of children born preterm less than 32 weeks in the 5-7 age period will be affected compared to their healthy controls. Identifying these situations according to their healthy peers will improve the general health of premature births and enable better intervention methods to be designed.

NCT ID: NCT04562766 Recruiting - Clinical trials for Immune Thrombocytopenia

Study to Evaluate Rilzabrutinib in Adults and Adolescents With Persistent or Chronic Immune Thrombocytopenia (ITP)

LUNA 3
Start date: December 14, 2020
Phase: Phase 3
Study type: Interventional

This is a randomized, double-blind study of rilzabrutinib in participants with persistent or chronic ITP, with an average platelet count of <30,000/μL (and no single platelet count >35,000/μL) on two counts at least 5 days apart in the 14 days before treatment begins. Participants will receive rilzabrutinib or placebo 400mg twice daily. For each participant, the study will last up to 60 weeks from the start of the Screening Period to the End of Study (EOS) visit. This includes Screening (up to 4 weeks) through a 12 to 24-week Blinded Treatment Period followed by a 28-week Open-Label Period. Followed by a 4-week post dose follow-up. For adult participants, the maximum duration of the long-term extension (LTE) period will be 12 months from the date of the last adult participant to enter the LTE. For pediatric participants, the maximum duration of the LTE period will be 12 months from the date of the last pediatric participant to enter the LTE.

NCT ID: NCT04562415 Completed - Stroke Clinical Trials

The Effect Of Transcranial Magnetic Stimulation In Patients With Stroke

Start date: October 1, 2018
Phase: N/A
Study type: Interventional

This study is aimed to investigate the effect of continuous theta burst stimulation (cTBS) and low frequency repetitive transcranial magnetic stimulation (rTMS) on upper extremity spasticity and functional recovery in patients with chronic ischemic stroke.

NCT ID: NCT04562220 Completed - Stroke Patients Clinical Trials

The Effect of Vibration Applied on Forearm Extensor Muscles Patients With Stroke

Start date: September 15, 2020
Phase: N/A
Study type: Interventional

This study was planned to determine the effect of vibration applied to forearm extensor muscles on hand functions and muscle activation in stroke patients.

NCT ID: NCT04562155 Completed - Clinical trials for Refractory and/or Unexplained Chronic Cough

Clinical Study to Evaluate the Efficacy and Safety of Three Different Doses of BAY1817080 Compared to Placebo in Patients With Chronic Cough

PAGANINI
Start date: October 2, 2020
Phase: Phase 2
Study type: Interventional

Researchers in this study want to find the optimal therapeutic dose of drug BAY1817080 for patients with long-standing cough with or without clear causes (refractory and/or unexplained chronic cough, RUCC). Study drug BAY1817080 is a new drug under development for the treatment of long-standing cough. It blocks proteins that are expressed by the airway sensory nerves which are oversensitive in patients with long-standing cough. This prevents the urge to cough. Researchers also want to learn the safety of the study drug and how well it works in reducing the cough frequency, severity and urge-to-cough. Participants in this study will receive either the study drug or placebo (a placebo looks like the test drug but does not have any medicine in it) tablets twice daily for 12 weeks. Observation for each participant will last about 18 weeks in total. Participants will be asked to wear a digital device to record the cough and to complete questionnaires every day to document the symptoms. Blood samples will be collected from the participants to monitor the safety and measure the blood level of the study drug.

NCT ID: NCT04561947 Completed - Gingival Recession Clinical Trials

Treatment of Gingival Recessions With Connective Tissue or Concentrated Growth Factor Membrane Using Tunnel Technique

Start date: October 1, 2017
Phase: N/A
Study type: Interventional

This randomized controlled clinical study aimed to evaluate the success of the combination of tunnel technique and concentrated growth factor membrane for root coverage in treating multiple gingival recessions and compare with the gold standard connective tissue graft.